Reaction
Central Hypothyroidism reporting signals
As of the last recalculation, Central Hypothyroidism appears in 305 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is MERCAPTOPURINE (PRR 135.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mercaptopurine | 31 | 135.7 | 135.9 |
| Tretinoin | 12 | 105.0 | 105.1 |
| Vincristine Sulfate | 37 | 97.9 | 98.0 |
| Doxorubicin | 77 | 78.5 | 78.6 |
| Cytarabine | 55 | 76.0 | 76.1 |
| Oxcarbazepine | 32 | 74.9 | 75.0 |
| Melphalan | 23 | 74.5 | 74.6 |
| Doxorubicin Hydrochloride | 31 | 72.0 | 72.1 |
| Dexamethasone Sodium Phosphate | 10 | 69.4 | 69.5 |
| Melphalan Hydrochloride | 23 | 67.6 | 67.7 |
| Busulfan | 14 | 63.6 | 63.6 |
| Etoposide | 42 | 45.1 | 45.1 |
| Ipilimumab | 25 | 43.0 | 43.0 |
| Cisplatin | 39 | 38.9 | 38.9 |
| Suvorexant | 7 | 37.7 | 37.7 |
| Thiotepa | 4 | 29.0 | 29.0 |